샘플 요청 목록

 카트 문의
시장보고서
상품코드
1656212

세계의 유전체학 분야 인공지능(AI) 시장

Artificial Intelligence (AI) in Genomics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 210 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유전체학 분야 인공지능(AI) 세계 시장은 2030년까지 87억 달러에 달할 전망

2024년에 11억 달러로 추정되는 유전체학 분야 인공지능(AI) 세계 시장은 2024년부터 2030년까지 CAGR 40.6%로 성장하여 2030년에는 87억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 유전체학 AI 소프트웨어는 CAGR 43.7%를 기록하고, 분석기간 종료까지 46억 달러에 달할 것으로 예측됩니다. 유전체학 AI 서비스 분야의 성장률은 분석기간 동안 CAGR 39.7%로 추정됩니다.

미국 시장은 3억 1,940만 달러로 추정, 중국은 CAGR 37.4%로 성장 예측

미국의 유전체학 분야 인공지능(AI) 시장은 2024년에 3억 1,940만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 12억 달러의 시장 규모에 달할 것으로 예측되며, 분석기간인 2024-2030년 CAGR은 37.4%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석기간 동안 CAGR은 각각 36.5%와 33.7%로 예측됩니다. 유럽에서는 독일이 CAGR 25.8%로 성장할 것으로 예측됩니다.

세계의 유전체학 분야 인공지능(AI) 시장 - 주요 동향과 촉진요인 정리

인공지능(AI)은 유전체학에 혁명을 일으켜 유전체 시퀀싱과 유전자 분석의 정확성과 속도를 크게 향상시키고 있으며, AI를 유전체학에 통합함으로써 연구자와 의료진이 유전 물질을 더 빨리 해독하고 개인의 유전자 프로필에 맞는 치료 계획을 수립할 수 있게함으로써 맞춤형 의료의 발전을 촉진하고 있습니다. 맞춤형 의료의 진보를 촉진할 수 있습니다. 전자 의료 기록에서 얻은 방대한 데이터세트를 처리할 수 있는 AI의 능력은 의료, 농업, 환경 과학에 적용 범위를 넓혀 보다 정밀한 질병 관리와 치료법 선택에 기여하고 있습니다. 예를 들어, AI 알고리즘은 환자의 건강 상태 궤적을 분석하고 기존 방법보다 더 높은 정확도로 결과를 예측할 수 있기 때문에 개인화된 의료 접근 방식과 치료법 개발에 큰 영향을 미칠 수 있습니다.

AI는 복잡한 유전자 데이터를 분석하여 효과적인 개입을 설계할 수 있는 도구를 제공함으로써 유전자 치료에서 매우 중요한 역할을 하고 있습니다. RNA 시퀀싱 기술, 특히 RNA-Seq는 유전자 발현과 돌연변이를 보다 정확하게 정량화하여 생물학적 과정과 잠재적 질병 메커니즘에 대한 더 깊은 인사이트를 제공함으로써 AI의 도움을 받아 질병을 유전자 수준에서 이해하고 치료하는 데 필수적입니다. 이러한 발전은 연구 속도를 가속화할 뿐만 아니라 치료와 유전자 치료의 질과 효과를 개선하고 현대 의학 및 과학적 이해의 한계를 뛰어넘는 데 있어 AI가 중요한 역할을 하고 있음을 강조합니다.

그러나 AI를 유전체학에 통합하는 것은 특히 유전자 데이터 보호와 프라이버시, 유전자 편집의 도덕적 의미와 같은 중대한 도전과 윤리적 고려 사항을 제기하고, AI와 유전체학의 결합이 강화됨에 따라 민감한 유전 정보의 보안을 보장하고 엄격한 규제 표준을 준수하는 것이 가장 중요합니다. 또한, 디자이너 유전자를 만들 수 있는 가능성에 대한 윤리적 논의는 이러한 기술을 어떻게 적용할 것인지에 대한 신중한 검토가 필요함을 강조하고 있습니다. 유전체학 분야에서 AI의 성장은 AI와 머신러닝 기술의 발전, 유전체 데이터의 급격한 증가, 정밀의료에 대한 관심 증가의 요인도 뒷받침하고 있습니다. 또한, 시퀀싱 비용의 감소, 의약품 개발에 대한 수요, 전략적 제휴, 민관 투자 증가 등이 모두 유전체 분야에서의 AI 적용 확대에 기여하고 있으며, 이는 이 분야를 더욱 발전시키고 헬스케어 및 의료의 다양한 측면에 미치는 영향을 확대할 것으로 예상됩니다.

부문

컴포넌트(소프트웨어, 서비스, 하드웨어), 기술(머신러닝, 기타 기술), 기능(유전체 시퀀싱, 유전자 편집, 기타 기능), 애플리케이션(신약개발, 정밀의료, 진단, 기타 애플리케이션), 최종사용자(제약 및 생명공학 기업, 병원 및 의료 서비스 제공자, 연구센터, 기타 최종사용자)

조사 대상 기업 사례(주목 23개사)

  • Data4Cure
  • Deep Genomics
  • Fabric Genomics(formerly Omicia)
  • Freenome, Inc.
  • Genoox
  • IBM Corporation
  • Illumina, Inc.
  • Microsoft Corporation
  • NVIDIA Corporation
  • Sophia Genetics

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.03.05

Global Artificial Intelligence (AI) in Genomics Market to Reach US$8.7 Billion by 2030

The global market for Artificial Intelligence (AI) in Genomics estimated at US$1.1 Billion in the year 2024, is expected to reach US$8.7 Billion by 2030, growing at a CAGR of 40.6% over the analysis period 2024-2030. Genomics AI Software, one of the segments analyzed in the report, is expected to record a 43.7% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Genomics AI Services segment is estimated at 39.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.4 Million While China is Forecast to Grow at 37.4% CAGR

The Artificial Intelligence (AI) in Genomics market in the U.S. is estimated at US$319.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 37.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 36.5% and 33.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 25.8% CAGR.

Global Artificial Intelligence (AI) in Genomics Market - Key Trends and Drivers Summarized

Artificial Intelligence (AI) is revolutionizing genomics, significantly enhancing the accuracy and speed of genome sequencing and genetic analysis. By integrating AI with genomics, researchers and healthcare providers can more quickly decode genetic material, facilitating advancements in personalized medicine where treatment plans are tailored to individual genetic profiles. AI's capacity to handle vast datasets gleaned from electronic medical records has expanded its applications across healthcare, agriculture, and environmental science, contributing to more targeted disease management and therapy options. For instance, AI algorithms can analyze patient health trajectories and predict outcomes with greater precision than traditional methods, profoundly impacting the development of personalized medical approaches and treatments.

In gene therapy, AI plays a pivotal role by providing tools to design effective interventions by analyzing complex genetic data. This capability is vital in enhancing the understanding and treatment of diseases at the genetic level. RNA sequencing technologies, especially RNA-Seq, benefit from AI by offering more accurate quantifications of gene expressions and their variations, thus providing deeper insights into biological processes and potential disease mechanisms. These advancements are not only accelerating the pace of research but also improving the quality and effectiveness of medical treatments and gene therapies, underscoring the critical role of AI in pushing the boundaries of modern medicine and scientific understanding.

However, the integration of AI into genomics raises significant challenges and ethical considerations, particularly concerning the protection and privacy of genetic data and the moral implications of genetic editing. Ensuring the security of sensitive genetic information and adhering to strict regulatory standards are paramount as AI and genomics become more intertwined. Moreover, ethical debates surrounding the potential for creating designer genes highlight the need for careful consideration of how these technologies are applied. The growth of AI in genomics is also driven by factors such as advancements in AI and machine learning technologies, the exponential increase in genomic data, and the growing emphasis on precision medicine. Additionally, reduced sequencing costs, the demand for drug development, strategic collaborations, and increased public and private investment all contribute to the expansion of AI applications in genomics, promising to further advance the field and expand its impact on various aspects of healthcare and medicine.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Genomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware); Technology (Machine Learning, Other Technologies); Functionality (Genome Sequencing, Gene Editing, Other Functionalities); Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Other Applications); End-User (Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 23 Featured) -

  • Data4Cure
  • Deep Genomics
  • Fabric Genomics (formerly Omicia)
  • Freenome, Inc.
  • Genoox
  • IBM Corporation
  • Illumina, Inc.
  • Microsoft Corporation
  • NVIDIA Corporation
  • Sophia Genetics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Intelligence (AI) in Genomics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Driven Gene Editing is Finally Here!
    • Data Analysis Acceleration by AI Spurs Growth in Genomic Research
    • AI for Predictive Genomics Expand Market Opportunities
    • Integration of AI with CRISPR Technology Strengthens Business Case for Genetic Engineering
    • Enhanced Newborn Screening Capabilities Through AI-Driven Genomic Interpretations
    • AI-Enhanced Diagnostic Tools for Genetic Disorders Drive Clinical Adoption
    • AI's Role in Oncology Genomics Throws the Spotlight On Cancer Treatment
    • AI-Powered Therapeutic Discovery Drives Innovations in Drug Development
    • AI's Impact on Agricultural Genomics Spurs Advances in Crop Science
    • AI in Genomic Data Privacy Issues Shape Regulatory and Ethical Debates
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence (AI) in Genomics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Intelligence (AI) in Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 4: World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 10: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 13: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Precision Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 16: World 8-Year Perspective for Precision Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 19: World 8-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 25: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 28: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 31: World 8-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 34: World 8-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 37: World 8-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 40: World 8-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 43: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 46: World 8-Year Perspective for Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Gene Editing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 49: World 8-Year Perspective for Gene Editing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 52: World 8-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 53: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 55: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 58: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 61: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 64: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 67: USA 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 70: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 73: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 76: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 79: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 82: Canada 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 85: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 88: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 91: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 94: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 97: Japan 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 98: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 100: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 103: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 106: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 109: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 112: China 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 115: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 118: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 121: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 124: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 127: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 130: Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 131: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 133: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 136: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 139: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 142: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 145: France 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 148: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 151: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 154: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 157: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 158: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Germany Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 160: Germany 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • ITALY
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 163: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 166: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 169: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 170: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 172: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 173: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Italy Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 175: Italy 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 176: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 178: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 179: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 181: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 182: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UK Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 184: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 185: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UK Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 187: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 188: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UK Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 190: UK 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Genomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030
  • REST OF WORLD
    • TABLE 221: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Component - Software, Services and Hardware Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 223: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Component - Percentage Breakdown of Value Sales for Software, Services and Hardware for the Years 2022, 2025 & 2030
    • TABLE 224: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Application - Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 226: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Application - Percentage Breakdown of Value Sales for Precision Medicine, Diagnostics, Other Applications and Drug Discovery & Development for the Years 2022, 2025 & 2030
    • TABLE 227: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by End-user - Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 229: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Healthcare Providers, Research Centers and Other End-Users for the Years 2022, 2025 & 2030
    • TABLE 230: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Technology - Machine Learning and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 232: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Technology - Percentage Breakdown of Value Sales for Machine Learning and Other Technologies for the Years 2022, 2025 & 2030
    • TABLE 233: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of World Historic Review for Artificial Intelligence (AI) in Genomics by Functionality - Genome Sequencing, Gene Editing and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2023 and % CAGR
    • TABLE 235: Rest of World 8-Year Perspective for Artificial Intelligence (AI) in Genomics by Functionality - Percentage Breakdown of Value Sales for Genome Sequencing, Gene Editing and Other Functionalities for the Years 2022, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제